Marti M C, Auckenthaler R
Surgery. 1983 Jan;93(1 Pt 2):190-6.
A prospective, randomized clinical trial was undertaken to compare the value of a combination of two antibiotics for the prevention of postoperative septic complications after large bowel surgery. In group I the patients received three doses daily for 2 days of 80 mg gentamicin and 600 mg clindamycin, intravenously. Patients in group II received three doses daily for 2 days of 80 mg gentamicin and 500 mg metronidazole. Antibiotic administration was started in the operating room before the surgical procedure. The two antibiotics were administered by separate venous routes. One hundred and seven patients were allocated to either one of the two groups. Both groups were equally matched for gender, age, and surgical procedure. Bacteriologic specimens were taken in the wound as soon as the peritoneum was closed. They were immediately incubated for identification by aerobic and anaerobic cultures and sensitivity determinations. Cultures of one or more organisms were positive in 63 of 107 specimens. There was no difference between the two groups. No death occurred as a result of intra-abdominal complication, no reoperation was required, and in no case did peritonitis occur. Six wound abscesses and three delayed stitch infections were observed: five in group I and two in group II. Five clinical anastomotic leakages were observed (5.1%): two in group I and three in group II. They did not require treatment and healed spontaneously. Furthermore, five radiologic anastomotic leakages were present in 45 patients who received a control barium enema. No side effects were noted with metronidazole of with clindamycin. No clinical evidence of ototoxicity or nephrotoxicity was observed in patients receiving gentamicin. There is no statistically significant clinical difference between the combination of gentamicin and metronidazole or gentamicin and clindamycin. Both combinations are effective in preventing wound sepsis in large bowel surgery. Metronidazole and clindamycin were equally effective in preventing postoperative anaerobic infections. No resistance of anaerobic organisms to metronidazole was observed.
进行了一项前瞻性随机临床试验,以比较两种抗生素联合使用对预防大肠手术后脓毒症并发症的价值。第一组患者静脉注射80毫克庆大霉素和600毫克克林霉素,每日3次,共2天。第二组患者静脉注射80毫克庆大霉素和500毫克甲硝唑,每日3次,共2天。抗生素在手术前于手术室开始给药。两种抗生素通过不同的静脉途径给药。107名患者被分配到两组中的一组。两组在性别、年龄和手术方式方面匹配良好。腹膜关闭后立即在伤口处采集细菌学标本。标本立即进行需氧和厌氧培养及药敏测定以进行鉴定。107份标本中有63份培养出一种或多种阳性菌。两组之间无差异。没有因腹腔内并发症导致死亡,无需再次手术,也未发生腹膜炎。观察到6例伤口脓肿和3例延迟缝线感染:第一组5例,第二组2例。观察到5例临床吻合口漏(5.1%):第一组2例,第二组3例。这些吻合口漏无需治疗,自行愈合。此外,45例行对照钡灌肠的患者中有5例存在放射学吻合口漏。未观察到甲硝唑或克林霉素的副作用。接受庆大霉素治疗的患者未出现耳毒性或肾毒性的临床证据。庆大霉素与甲硝唑或庆大霉素与克林霉素联合使用在临床方面无统计学显著差异。两种联合用药在预防大肠手术伤口感染方面均有效。甲硝唑和克林霉素在预防术后厌氧菌感染方面同样有效。未观察到厌氧菌对甲硝唑耐药。